Christopher A. Lazarski

A reappraisal of CTLA-4 checkpoint blockade in cancer immunotherapy

Xuexiang Du, Fei Tang, Mingyue Liu et al. · Cell Research · 2018 · 246 citations · Full text

Life Sciences, Immunology, Oncology +17

The Kinetic Stability of MHC Class II:Peptide Complexes Is a Key Parameter that Dictates Immunodominance

Christopher A. Lazarski, Francisco A. Chaves, Scott A. Jenks et al. · Immunity · 2005 · 228 citations · Full text

Life Sciences, Immunology, Molecular Biology +15

High-Intensity Focused Ultrasound (HIFU) Triggers Immune Sensitization of Refractory Murine Neuroblastoma to Checkpoint Inhibitor Therapy

Avinash Eranki, Priya Srinivasan, Mario Ries et al. · Clinical Cancer Research · 2019 · 173 citations · Full text

Medicine, Immunology, Oncology +17

Fibroadipogenic progenitors are responsible for muscle loss in limb girdle muscular dystrophy 2B

Marshall W. Hogarth, Aurélia Defour, Christopher A. Lazarski et al. · Nature Communications · 2019 · 150 citations · Full text

Medicine, Genetics, Molecular Biology +17

SARS-CoV-2–specific T cells are rapidly expanded for therapeutic use and target conserved regions of the membrane protein

Michael D. Keller, Katherine M. Harris, Mariah Jensen-Wachspress et al. · Blood · 2020 · 139 citations · Full text

Life Sciences, Immunology, Infectious Diseases +8